Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...
Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...
Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...
AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...
ImaginAb, a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...
Correvio Pharma Corp, a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs h...
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to pr...
Alexion Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS&trad...
PolarityTE, Inc., a commercial-stage biotechnology company focused on transforming the lives of patients by discovering,...
George A. Williams, M.D, today begins his term as the 123rd president of the American Academy of Ophthalmology (AAO). Dr...
Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innova...
Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...
Nuvo Pharmaceuticals Inc. a globally focused, Canadian healthcare company with a portfolio of commercial products today ...
Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...
